Key result
Antihypertensive therapy plus lifestyle changes cuts clinical events ~31% vs. lifestyle advice alone.
Why the study?
Comparative effectiveness of six antihypertensive interventions for mild hypertension had not been established.
Does antihypertensive drug treatment combined with nutritional-hygienic advice reduce blood pressure and cardiovascular events in adults with mild hypertension compared to nutritional-hygienic advice alone?
RCT (n=902)
Double-blind
Randomized
Yes
Does antihypertensive drug treatment combined with nutritional-hygienic advice reduce blood pressure and cardiovascular events in adults with mild hypertension compared to nutritional-hygienic advice alone?
In patients with mild hypertension, initial drug treatment combined with nutritional-hygienic intervention is more effective than nutritional-hygienic treatment alone in lowering blood pressure and preventing clinical events.
Answers are grounded in this paper and cite their sources.
Supports combined drug-lifestyle therapy as initial strategy in mild hypertension; confirms event reduction versus lifestyle intervention alone.
OBJECTIVE: To compare six antihypertensive interventions for the treatment of mild hypertension. DESIGN: Randomized, double-blind, placebo-controlled clinical trial. SETTING: Four hypertension screening and treatment centers in the United States. PARTICIPANTS: Hypertensive men and women, aged 45 to 69 years, with diastolic blood pressure less than 100 mm Hg. INTERVENTION: Sustained nutritional-hygienic advice to all participants to reduce weight, dietary sodium intake, and alcohol intake, and increase physical activity. Participants were randomly allocated to take (1) placebo (n = 234); (2) chlorthalidone (n = 136); (3) acebutolol (n = 132); (4) doxazosin mesylate (n = 134); (5) amlodipine maleate (n = 131); or (6) enalapril maleate (n = 135). MAIN OUTCOME MEASURES: Blood pressure, quality of life, side effects, blood lipid levels and analysis of other serum components, echocardiographic and electrocardiographic changes, and incidence of cardiovascular events over an average of 4.4 years of follow-up. RESULTS: Blood pressure reductions were sizable in all six groups, and were significantly greater for participants assigned to drug treatment than placebo (-15.9 vs -9.1 mm Hg for systolic blood pressure and -12.3 vs -8.6 mm Hg for diastolic blood pressure; P < .0001). After 4 years, 59% of participants assigned to placebo and 72% of participants given drug treatment continued on their initial medication as monotherapy. A smaller percentage of participants assigned to the drug-treatment groups died or experienced a major nonfatal cardiovascular event than those assigned to the placebo group (5.1% vs 7.3%; P = .21). After including other clinical events, the percentage of participants affected was 11.1% for those in the drug-treatment groups and 16.2% for those in the placebo group (P = .03). Incidence rates of most resting electrocardiographic abnormalities were lower and quality of life was improved more for those assigned to drug-treatment groups rather than the placebo group. Differences among the five drug treatments did not consistently favor one group in terms of regression of left ventricular mass, blood lipid levels, and other outcome measures. CONCLUSIONS: As an initial regimen, drug treatment in combination with nutritional-hygienic intervention was more effective in preventing cardiovascular and other clinical events than was nutritional-hygienic treatment alone. Drug-treatment group differences were minimal. Pending results from large-scale clinical trials to evaluate drug treatments for their effect on cardiovascular clinical events, these findings support the recommendations of the new fifth Joint National Committee report regarding treatment choices for people with stage 1 ("mild") hypertension.
No takes yet. Share an insight, caveat, or question.
J. D. Neaton (1993) conducted an RCT in Mild hypertension (n=902). Antihypertensive drug treatment (chlorthalidone, acebutolol, doxazosin, amlodipine, or enalapril) plus nutritional-hygienic advice vs. Placebo plus nutritional-hygienic advice was evaluated on Cardiovascular and other clinical events (p=.03). Antihypertensive drug treatment combined with nutritional-hygienic intervention reduced cardiovascular and other clinical events compared to placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: